Detalhe da pesquisa
1.
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.
Nat Cancer
; 2(8): 794-802, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118423
2.
Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153-163].
Eur J Cancer
; 137: 290-291, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723589